NANO MRNA Co.,Ltd.
4571
Rank in Stocks
#23529
NANO MRNA Co., Ltd. specializes in the discovery, advancement, and... NANO MRNA Co., Ltd. specializes in the discovery, advancement, and manufacturing of pharmaceutical products, employing its innovative micellar nanoparticle platform. Its biopharmaceutical pipeline is primarily geared towards addressing oncological conditions and a range of other severe illnesses. The enterprise also undertakes the full spectrum of activities for anti-cancer medications, from initial scientific investigation to market commercialization, all underpinned by its distinctive micellar nanoparticle approach. Established on June 14, 1996, by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi, the firm maintains its principal operations in Tokyo, Japan.
Share Price
$0.45573515
Last synced: 2026-11-10
Market Cap
$41.44M
Change (1 day)
0.00%
Change (1 year)
-55.84%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade NANO MRNA Co.,Ltd. (4571)
Category
Healthcare
Operating Margin for NANO MRNA Co.,Ltd. (4571)
Operating Margin as of November 2026 TTM: -519.56%
According to NANO MRNA Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is -519.56%. At the end of 2025 the company had an operating margin of -696.07%.
Operating Margin history for NANO MRNA Co.,Ltd. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -519.56% | -25.36% |
| 2025 | -696.07% | 9.12% |
| 2024 | -637.91% | 3.51% |
| 2023 | -616.26% | -21.06% |
| 2022 | -780.62% | 87.69% |
| 2021 | -415.91% | 107.99% |
| 2020 | -199.97% | -44.89% |
| 2019 | -362.83% | -82.43% |
| 2018 | -2,065.42% | 66.54% |
| 2017 | -1,240.19% | 44.91% |
| 2016 | -855.86% | 421.90% |
| 2015 | -163.99% | -31.05% |
| 2014 | -237.83% | 68.76% |
| 2013 | -140.93% | 46.33% |
| 2012 | -96.31% | -84.38% |
| 2011 | -616.49% | 47.42% |
| 2010 | -418.18% | 178.08% |
| 2009 | -150.38% | -12.70% |
| 2008 | -172.25% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.07% |
US
|
|
| -149.01% | -99.71% |
US
|
|
| 25.57% | -100.05% |
AU
|
|
| 31.23% | -100.06% |
BE
|
|
| 29.35% | -100.06% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about NANO MRNA Co.,Ltd.'s operating margin
What is NANO MRNA Co.,Ltd.'s operating margin?
NANO MRNA Co.,Ltd.'s operating margin is -519.56%, as of Nov 2026.
What was NANO MRNA Co.,Ltd.'s operating margin in 2025?
In 2025, NANO MRNA Co.,Ltd.'s operating margin was -696.07%, compared with -637.91% in 2024.
How has NANO MRNA Co.,Ltd.'s operating margin changed since 2020?
From 2020 to 2025, NANO MRNA Co.,Ltd.'s operating margin was highest in 2020 (-199.97%) and lowest in 2022 (-780.62%).
How does NANO MRNA Co.,Ltd.'s operating margin compare with similar companies?
NANO MRNA Co.,Ltd.'s operating margin (-519.56%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.